Conclusion This case report demonstrates that the combination of prolonged water fasting and a GLP-1 receptor agonist is a safe and effective method for short-term substantial weight loss in patients with severe obesity for the purpose of pre-procedural optimization prior to bariatric surgery, and may result in the improvement of multiple chronic diseases including hypertension, insulin resistance, anemia, depression, and diastolic heart failure
A 2023 retrospective cohort study published in Diabetes Care found that approximately 20% of patients initiated on a GLP-1 RA switched agents within the first 12 months, with GI intolerance and cost as the two most commonly documented reasons [7]
Performance metrics and customer outcomes represent reported experiences that may vary based on facility configuration, existing workflows, staff adoption, and payer mix
Am J Manag Care 2016;22:s176-85
Many clients find that the lowered appetite while taking the medication makes it easier to form healthier habits